| Morning Session 8:15 am to 10:15 am |
- Welcome to Stanford
Gary K. Steinberg MD, PhD
- Introduction:
Why the need for an "active international working group"
Nadia Khan MD
- Burden of Disease in the UK
Martin Brown MD
- Genetics of Familial Moyamoya Disease
Yohei Mineharu MD, PhD
- Direct and Indirect Revascularization for European Adult Moyamoya Angiopathy
Daniel Haenggi MD
- The Stanford experience
Gary K. Steinberg MD, PhD
|
View videos |
| Morning Session 10:35 am to 12:05 pm |
- Management of Childhood Moyamoya Disease, Non-invasive Biomarkers in Moyamoya
Edward R. Smith M.D
- EPC in cerebrovascular disease, focusing on Moyamoya disease
Jae-Kyu Roh, MD
- Management of Headache, Hypertension and Systemic Diseases in Moyamoya Angiopathy
Vijeya Ganesan MD
|
View videos |
| Afternoon Session 1:00 pm to 3:10 pm |
- Novel Gene(s) for Moyamoya Disease: Insight into the Pathogenesis
Keynote Speaker: Dianna Milewicz MD, PhD
- Intraoperative Infrared Brain Surface Monitoring During STA-MCA Anastomosis in Moyamoya Disease: Implication for Detection and Management of Postoperative Hyperperfusion
Atsuhiro Nakagawa MD, PhD
- Unilateral Intracranial Childhood Arteriopathies
Kees Braun MD
- Recent trends in adult moyamoya disease: Results from a nationwide survey
Mario Zuccarello MD
|
View videos |
| Afternoon Session 3:30 pm to 5:50 pm |
- Asymptomatic Patients with Moyamoya: Should they be treated with Surgical Revascularization
Catharina Klijn MD
- Clinical and Quantitative Angiographic Outcomes from Indirect Revascularization Surgery for Moyamoya Disease
Nestor Gonzalez MD
- Clinical Features, Surgical Treatment, and Long-Term Outcome of Adult Moyamoya Patients
Robert Starke MD, MSC
- Direct STA-MCA and STA-ACA bypass in European moyamoya angiopathy
Nadia Khan, MD
- Closing remarks
|
View videos |
